RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
Clinical trial NCT06492317 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06492317
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-06
- Primary completion
- 2026-07-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.